ArticleCancer research2024

ASCL1 Drives Tolerance to Osimertinib in EGFR Mutant Lung Cancer in Permissive Cellular Contexts.

Bomiao Hu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.